VYNE Therapeutics (VYNE)
(Delayed Data from NSDQ)
$1.84 USD
+0.05 (2.79%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $1.84 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Earnings News For VYNE
-
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Tops Revenue Estimates
-
VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
-
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
-
VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update
-
VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
VYNE Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
-
VYNE Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
-
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates
-
VYNE Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Misses Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Lags Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) Reports Q4 Loss, Misses Revenue Estimates